NCT01316250 2025-10-02
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
American University of Beirut Medical Center
Phase NA Completed
Clinical Trials
3 trialsNCT00049569 2013-10-08
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Phase NA Completed
NCT00386373 2012-08-01
Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
M.D. Anderson Cancer Center
Phase NA Completed